Advertisement

Topics

Public offering nets $203mm for Reata

15:40 EDT 26 Jul 2018 | Elsevier Business Intelligence

Reata Pharmaceuticals Inc. (developing drugs targeting molecular pathways that regulate inflammation and cellular metabolism)...

Original Article: Public offering nets $203mm for Reata

NEXT ARTICLE

More From BioPortfolio on "Public offering nets $203mm for Reata"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Nephrology - kidney function
Nephrology is a specialty of medicine and pediatrics that concerns itself with the study of normal kidney function, kidney problems, the treatment of kidney problems and renal replacement therapy (dialysis and kidney transplantation). Systemic conditions...